Home › Funds › Split Rock Private Trading & Wealth Management, LLC › ELDN
Split Rock Private Trading & Wealth Management, LLC position in ELDN
ELEDON PHARMACEUTICALS INC · Health Care
Split Rock Private Trading & Wealth Management, LLC reported holding 10,000 shares of ELDN (ELEDON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$25K, representing 0.02% of its reported portfolio and ranking #50 among its reported holdings. Split Rock Private Trading & Wealth Management, LLC has disclosed ELDN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Split Rock Private Trading & Wealth Management, LLC's ELDN position evolved
Split Rock Private Trading & Wealth Management, LLC first disclosed a stake in ELDN in Q4 2025 at 10,000 shares (US$15K). The position peaked in Q2 2026 at 10,000 shares, worth US$39K. Across 4 filings, Split Rock Private Trading & Wealth Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 10,000 shares valued at US$25K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 10.00K | $15.10K | New |
| Q1 2026 | 10.00K | $30.80K | Hold |
| Q2 2026 | 10.00K | $39.40K | Hold |
| Q3 2026 | 10.00K | $25.30K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELDN and 13F data
ELDN (ELEDON PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in ELDN — the largest reported positions include BVF INC/IL (US$24.8M), Defilade Capital Management, L.P. (US$13.9M), Catalio Capital Management, LP (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELDN
- BVF INC/IL 6.29M sh · $24.80M · Q2 2026
- Defilade Capital Management, L.P. 3.53M sh · $13.89M · Q2 2026
- Catalio Capital Management, LP 1.70M sh · $6.68M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 1.19M sh · $4.69M · Q2 2026
- 22NW, LP 636.36K sh · $2.51M · Q2 2026
- CM Management, LLC 575.00K sh · $2.27M · Q2 2026
More on Split Rock Private Trading & Wealth Management, LLC
FAQ
How long has Split Rock Private Trading & Wealth Management, LLC held ELDN?
Split Rock Private Trading & Wealth Management, LLC has disclosed ELDN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Split Rock Private Trading & Wealth Management, LLC's current position in ELDN?
As of Q3 2026, Split Rock Private Trading & Wealth Management, LLC holds 10.00K shares of ELDN (ELEDON PHARMACEUTICALS INC), valued at $25.30K, representing 0.02% of its reported portfolio and ranking #50.
Has Split Rock Private Trading & Wealth Management, LLC been buying or selling ELDN?
In the latest 13F filing (Q3 2026), Split Rock Private Trading & Wealth Management, LLC held unchanged its position in ELDN. The position peaked in Q2 2026 at 10.00K shares.
Which other funds hold ELDN?
Other major institutional holders of ELDN include BVF INC/IL, Defilade Capital Management, L.P., Catalio Capital Management, LP, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.